Watch how the jiggling motion of bacterial DNA stops when a natural antimicrobial peptide permeates the E. coli membrane. This novel mechanism helps explain why bacteria develop resistance very slowly and may inform the design of new antimicrobial agents.Watch Now
Cigarettes aren’t good for us. That’s hardly news -- we’ve known about the dangers of smoking for decades. But how exactly do cigarettes harm us, and can our bodies recover if we stop? Krishna Sudhir details what happens when we smoke -- and when we quit.Watch Now
This animation explores how insights into the immunobiology of ulcerative colitis are helping researchers to develop innovative treatments.Watch Now
Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.
Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019